CHAMPIONS ONCOLOGY, INC. Quarterly Selling and Marketing Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Champions Oncology, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q2 2024.
  • Champions Oncology, Inc. Selling and Marketing Expense for the quarter ending July 31, 2024 was $1.68M, a 1% decline year-over-year.
  • Champions Oncology, Inc. Selling and Marketing Expense for the twelve months ending July 31, 2024 was $7.05M, a 0.59% increase year-over-year.
  • Champions Oncology, Inc. annual Selling and Marketing Expense for 2023 was $7.06M, a 0.89% increase from 2022.
  • Champions Oncology, Inc. annual Selling and Marketing Expense for 2022 was $7M, a 9.77% increase from 2021.
  • Champions Oncology, Inc. annual Selling and Marketing Expense for 2021 was $6.38M, a 15.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.05M $1.68M -$17K -1% May 1, 2024 Jul 31, 2024 10-Q 2024-09-13
Q1 2024 $7.06M $1.78M -$73K -3.95% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-19
Q4 2023 $7.14M $1.8M +$36K +2.04% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-15
Q3 2023 $7.1M $1.8M +$95K +5.59% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-13
Q2 2023 $7.01M $1.7M +$4K +0.24% May 1, 2023 Jul 31, 2023 10-Q 2024-09-13
Q1 2023 $7M $1.85M +$233K +14.4% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-19
Q4 2022 $6.77M $1.76M +$212K +13.7% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-15
Q3 2022 $6.56M $1.7M +$60K +3.66% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-13
Q2 2022 $6.5M $1.69M +$118K +7.5% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 $6.38M $1.62M +$144K +9.78% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-24
Q4 2021 $6.24M $1.55M +$57K +3.82% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $6.18M $1.64M +$292K +21.7% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-13
Q2 2021 $5.89M $1.57M +$366K +30.3% May 1, 2021 Jul 31, 2021 10-Q 2022-09-12
Q1 2021 $5.52M $1.47M +$384K +35.3% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-22
Q4 2020 $5.14M $1.49M +$185K +14.2% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $4.95M $1.35M +$371K +38% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 $4.58M $1.21M +$338K +38.9% May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
Q1 2020 $4.24M $1.09M +$169K +18.4% Feb 1, 2020 Apr 30, 2020 10-K 2021-07-26
Q4 2019 $4.07M $1.31M +$428K +48.7% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 $3.65M $977K +$237K +32% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-14
Q2 2019 $3.41M $870K +$352K +68% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $3.06M $919K +$210K +29.6% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-28
Q4 2018 $2.85M $879K +$252K +40.2% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $2.59M $740K +$189K +34.3% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-16
Q2 2018 $2.41M $518K -$165K -24.2% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $2.57M $709K -$184K -20.6% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-29
Q4 2017 $2.75M $627K -$99K -13.6% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 $2.85M $551K -$166K -23.2% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-17
Q2 2017 $3.02M $683K -$242K -26.2% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $3.26M $893K +$90K +11.2% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 $3.17M $726K -$53K -6.8% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 $3.22M $717K -$117K -14% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-15
Q2 2016 $3.34M $925K -$104K -10.1% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $3.45M $803K -$149K -15.7% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-28
Q4 2015 $3.59M $779K -$315K -28.8% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $3.91M $834K -$369K -30.7% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 $4.28M $1.03M -$5K -0.48% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $4.28M $952K -$42K -4.23% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 $4.33M $1.09M +$273K +33.3% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $4.05M $1.2M +$505K +72.4% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-15
Q2 2014 $3.55M $1.03M +$392K +61.1% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 $3.16M $994K +$376K +60.8% Feb 1, 2014 Apr 30, 2014 10-K 2015-07-29
Q4 2013 $2.78M $821K +$163K +24.8% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $2.62M $698K +$18K +2.65% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 $2.6M $642K -$67K -9.45% May 1, 2013 Jul 31, 2013 10-Q 2014-09-12
Q1 2013 $2.67M $618K -$348K -36% Feb 1, 2013 Apr 30, 2013 10-K 2014-07-28
Q4 2012 $3.01M $658K +$35K +5.62% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-14
Q3 2012 $2.98M $680K +$29K +4.46% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-13
Q2 2012 $2.95M $709K +$21K +3.05% May 1, 2012 Jul 31, 2012 10-Q 2013-09-13
Q1 2012 $2.93M $966K +$334K +52.8% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-26
Q4 2011 $2.59M $623K +$384K +161% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-13
Q3 2011 $2.21M $651K +$571K +714% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-13
Q2 2011 $1.64M $688K +$554K +413% May 1, 2011 Jul 31, 2011 10-Q 2012-09-12
Q1 2011 $1.09M $632K Feb 1, 2011 Apr 30, 2011 10-K 2012-07-18
Q4 2010 $239K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-14
Q3 2010 $80K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-14
Q2 2010 $134K May 1, 2010 Jul 31, 2010 10-Q 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.